Pharmaceutical company Eli Lilly announced promising clinical trial results for a daily pill to treat obesity and diabetes, a ...

Work has begun in the UK on developing new tests that will spot if someone has “fat genes”. The project, which seeks to ...

A Telford mum who lost three stone on weight loss drug Mounjaro says it wasn't "worth it" after it caused hair loss, made her ...

This article looks at the top three catalysts that will impact these ETFs like SPY, QQQ, and DIA later this week.

All 16 S&P 500 healthcare companies that reported quarterly results this week, delivered an earnings beat. On the top-line, Gilead Sciences (NASDAQ:GILD) was the only one which missed Wall Street's ...

Eli Lilly's dual GLP-1/GIP agonist tirzepatide has been shown to reduce the risk of worsening disease in people with heart failure and obesity in a phase 3 trial, the first to show a benefit on ...